GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (BOM:532488) » Definitions » E10

Divi's Laboratories (BOM:532488) E10 : ₹109.71 (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Divi's Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹22.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹109.71 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-29), Divi's Laboratories's current stock price is ₹5773.10. Divi's Laboratories's E10 for the quarter that ended in Dec. 2024 was ₹109.71. Divi's Laboratories's Shiller PE Ratio of today is 52.62.

During the past 13 years, the highest Shiller PE Ratio of Divi's Laboratories was 55.98. The lowest was 49.96. And the median was 52.62.


Divi's Laboratories E10 Historical Data

The historical data trend for Divi's Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories E10 Chart

Divi's Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Divi's Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 109.71

Competitive Comparison of Divi's Laboratories's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Divi's Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's Shiller PE Ratio falls into.


;
;

Divi's Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Divi's Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=22.2/158.3229*158.3229
=22.200

Current CPI (Dec. 2024) = 158.3229.

Divi's Laboratories Quarterly Data

per share eps CPI Adj_EPS
200603 2.661 45.521 9.255
200703 7.163 48.581 23.344
200803 13.308 52.407 40.204
200903 15.935 56.615 44.562
201003 13.030 65.030 31.723
201103 16.205 70.768 36.254
201203 20.095 76.889 41.378
201303 22.675 85.687 41.896
201403 29.130 91.425 50.445
201503 32.080 97.163 52.273
201603 42.410 102.518 65.495
201703 39.950 105.196 60.126
201803 33.040 109.786 47.647
201806 10.080 111.317 14.337
201809 15.210 115.142 20.914
201812 14.670 115.142 20.172
201903 11.000 118.202 14.734
201906 10.260 120.880 13.438
201909 13.440 123.175 17.275
201912 13.530 126.235 16.969
202003 14.620 124.705 18.561
202006 18.540 127.000 23.113
202009 19.570 130.118 23.812
202012 17.730 130.889 21.446
202103 18.910 131.771 22.720
202106 20.990 134.084 24.784
202109 22.840 135.847 26.619
202112 33.990 138.161 38.950
202203 33.700 138.822 38.434
202206 26.440 142.347 29.407
202209 18.600 144.661 20.357
202212 11.560 145.763 12.556
202303 12.090 146.865 13.033
202306 13.410 150.280 14.128
202309 13.110 151.492 13.701
202312 13.500 152.924 13.977
202403 20.250 153.035 20.950
202406 16.200 155.789 16.464
202409 19.200 157.882 19.254
202412 22.200 158.323 22.200

Add all the adjusted EPS together and divide 10 will get our e10.


Divi's Laboratories  (BOM:532488) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Divi's Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5773.10/109.71
=52.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Divi's Laboratories was 55.98. The lowest was 49.96. And the median was 52.62.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Divi's Laboratories E10 Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Divi's Laboratories Business Description

Traded in Other Exchanges
Address
Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines